中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:( Xianjun XIONG)

1.Analysis of Medicine Utilization Variation of Inpatient Participated Insurance after Implementing the 2009 Edition of National Reimbursement Drug List

Jie ZHANG ; Xianjun XIONG ; Jinghu LI

Chinese Health Economics 2014;(3):39-41

2.Health Equity and Health Performance of Urban Residents in China

Haijing GUAN ; Guoen LIU ; Xianjun XIONG

Chinese Health Economics 2013;(9):33-37

3.Appropriate doctor-seeking management model for hypertension patients under medical insurance in China's urban communities

Juyang XIONG ; Xiao YAN ; Lan YAO ; Xianjun XIONG

Chinese Journal of Hospital Administration 2011;27(4):260-264

4.Conditioned medium from lung carcinoma cell line A549 increases the viability of human umbilical vein endothelial cells by activating the PI3K-Akt1 pathway

Mingli TU ; Chang XIONG ; Xianjun LIU ; Guoshi LUO ; Chunling DU ; Yongjian XU

Tumor 2010;(2):109-114

5.Resting-state functional MRI of regional spontaneous brain activity in classical trigeminal neuralgia patients

Wenjuan XIONG ; Laichang HE ; Yongming TAN ; Fuqing ZHOU ; Xianjun ZENG ; Honghan GONG ; Zhi LI

Chinese Journal of Medical Imaging Technology 2017;33(9):1321-1325

6.Study on screening for 274 suspected cases of corona virus disease 2019

Xuli YANG ; Zhihui WANG ; Xing LIU ; Shanshan WU ; Xiaoping WU ; Guilan WEN ; Xianjun ZENG ; Huawei XIONG ; Jie LIU ; Tao HONG

Chinese Journal of Infectious Diseases 2020;38(4):199-203

7.Efficacy and safety of Tianmeng Oral Liquid in the treatment of hyperprolactinemia caused by antipsychotics in female patients with schizophrenia: a Meta-analysis

Xianjun LAN ; Zhenjuan QIN ; Qiman LIU ; Dongbin CAI ; Yaoyao LU ; Xiong HUANG ; Wei ZHENG

Sichuan Mental Health 2023;36(1):25-31

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO